Faculty Viewpoints

Yale SOM’s Jeffrey Sonnenfeld and Steven Tian and economists Paul Romer and Dirk Bergemann explain the arguments from each camp in the debate over artificial intelligence, from true believers to alarmists.

The headlines are full of grand and sometimes terrifying speculation about the potential of artificial intelligence. At Yale SOM’s CEO Summit recently, Prof. Jeffrey Sonnenfeld asked business leaders for some real talk about how their companies are using the technology.

Yale SOM’s Jeffrey Sonnenfeld and Steven Tian write that the exchange-traded funds that boycott companies taking action on social issues are underperforming the market and struggling to find investors.

As the risks of dependence on China become more apparent, a few companies are diversifying their supply chains. But inertia and short-term thinking are keeping many companies tethered to markets and suppliers in the world’s second-largest economy, write Yale SOM’s Jeffrey Sonnenfeld and Steven Tian and investor Kyle Bass.

Was the closure of Silicon Valley Bank in March a failure of regulation? Greg Feldberg, director of research at the Yale Program on Financial Stability, recently investigated what could have happened if tighter regulations had applied to SVB. He found that better rules could have made a difference.

In this extended video, Prof. Andrew Metrick, director of the Yale Program on Financial Stability, explains why Silicon Valley Bank failed earlier this year, and what the collapse tells us about banking, bailouts, and the nature of financial crises.

Yale SOM’s Jeffrey Sonnenfeld and Steven Tian and their team found that Connecticut’s return on its pension fund investments is among the worst in the nation. Their analysis of all 50 states offers some avenues for improvement.

Yale SOM leadership expert Jeffrey Sonnenfeld asks if the CEO’s eccentricities and forgotten promises are undermining his leadership of Twitter, Tesla, and SpaceX.

The first drugs using the CRISPR technique are approaching the market, with the potential to transform the lives of people with certain genetic illnesses. We talked with Dr. Greg Licholai about the state of the technology.

Yale SOM leadership expert Jeffrey Sonnenfeld writes that cynical media coverage and unwarranted concern over Biden’s age have muted the remarkable achievements of his first term.